Welcome to our dedicated page for Healthwarehouse news (Ticker: HEWA), a resource for investors and traders seeking the latest updates and insights on Healthwarehouse stock.
HealthWarehouse.com, Inc. (OTCQB: HEWA) is a healthcare e‑commerce and technology company that regularly publishes detailed financial and operational updates. As an NABP Approved Digital Pharmacy based in Florence, Kentucky, HealthWarehouse.com reports on its performance in selling and delivering prescription and over‑the‑counter medications to customers in all 50 states, serving both direct‑to‑consumer and partner services (B2B) channels.
On this page, readers can follow HEWA news that covers quarterly and annual results, trends in prescription and over‑the‑counter sales, and management’s commentary on business drivers. Company releases discuss net sales, gross profit, operating expenses, net income or loss, and non‑GAAP measures such as EBITDA and Adjusted EBITDA, along with explanations of how product mix and partner services margins affect these figures.
HealthWarehouse.com’s news flow often highlights the impact of GLP‑1 medications on its results, including brand and compounded GLP‑1 prescriptions fulfilled through its partner services and direct‑to‑consumer businesses. The company also reports on technology initiatives, such as new pharmacy software and a proprietary e‑commerce platform, and how these investments relate to patient experience, operational efficiency, and scalability.
Investors and observers can use this news feed to review management’s discussion of topics like cold‑chain shipping capabilities, changes in over‑the‑counter marketplace sales, and the evolution of its B2B partner services pipeline. For ongoing insight into HealthWarehouse.com’s operating trends, financial performance, and strategic focus areas, this HEWA news page aggregates the company’s latest publicly released updates.
HealthWarehouse.com, Inc. (OTCQB: HEWA) reported a net loss of $131,025 for Q1 2021, an increase from a loss of $68,428 in Q1 2020. Despite this, the company achieved a positive Adjusted EBITDA of $124,114. Net sales declined by 16% to $3,818,285, driven by decreased consumer demand and lower website traffic. Prescription sales fell by 9.9%, and over-the-counter sales decreased by 36.8%. Operating expenses decreased by 5.2%. Gross profit was $2,651,875, reflecting a 7.8% decrease, but gross margin improved to 69.5% through strategic purchasing efforts.
HealthWarehouse.com, Inc. (OTCQB:HEWA) has announced that its common stock will start trading on the OTCQB Market, enhancing investor visibility and potential liquidity. President Joseph Peters positioned this as a significant milestone, stating it could attract greater investor interest compared to the previous OTC Pink Sheets listing. The OTCQB requires companies to meet specific financial and reporting criteria, further strengthening its market position. HealthWarehouse.com offers affordable online pharmacy services nationwide, supporting its mission to deliver quality healthcare.
HealthWarehouse.com, Inc. (OTC:HEWA) reported a net income of $641,326 and net sales of $17,178,985 for 2020, marking a net income turnaround from a loss of $99,400 in 2019. Adjusted EBITDA was $593,744, down from $712,312 the previous year. The company saw a 9% rise in total net sales from 2019, driven by a 25% increase in over-the-counter sales amid COVID-19 demand. Operating expenses rose 12%, primarily due to staffing and variable costs. HealthWarehouse.com is preparing to launch new pharmacy software in Q3 2021, aiming to enhance operational efficiency.